Rosacea – Global Clinical Trial Pipeline Highlights, 2019: Track Competition, Identify Partners, Evaluate Opportunities, Formulate Business Development Strategies – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Rosacea
– Global Clinical Trial Pipeline Highlights, 2019” report has
been added to ResearchAndMarkets.com’s offering.

This report provides most up-to-date information on key pipeline
products in the global Rosacea market. It covers emerging therapies for
Rosacea in active clinical development stages including early and late
stage clinical trials.

The pipeline data presented in this report helps executives for tracking
competition, identifying partners, evaluating opportunities, formulating
business development strategies, and executing in-licensing and
out-licensing deals.

Clinical Trial Stages

The report provides Rosacea pipeline products by clinical trial stages
including both early and late stage development – phase 3 clinical
trials, phase 2 clinical trials, phase 1 clinical trials, preclinical
research, and discovery stage.

Drug Mechanism Classes

The report provides Rosacea pipeline products by their dominant
mechanism of action/drug class. This helps executives categorize
products based on their drug class and also assess the strengths and
weaknesses of compounds.

Company

The report provides Rosacea pipeline products by the company.

Short-term Launch Highlights

Find out which Rosacea pipeline products will be launched in the US and
Ex-US till 2024.

Key Topics Covered

1. Rosacea Pipeline by Stages

2. Rosacea Phase 3 Clinical Trial Insights

3. Rosacea Phase 2 Clinical Trial Insights

4. Rosacea Phase 1 Clinical Trial Insights

5. Rosacea Preclinical Research Insights

6. Rosacea Discovery Stage Insights

7. Appendix

8. Research Methodology

List of Tables

Table 1: Rosacea Phase 3 Clinical Trials, 2019

Table 2: Rosacea Phase 2 Clinical Trials, 2019

Table 3: Rosacea Phase 1 Clinical Trials, 2019

Table 4: Rosacea Preclinical Research, 2019

Table 5: Rosacea Discovery Stage, 2019

List of Figures

Figure 1: Rosacea Pipeline Molecules by Clinical Trials Stage, 2019

Figure 2: Rosacea Phase 3 Clinical Trial Highlights, 2019

Figure 3: Rosacea Phase 2 Clinical Trial Highlights, 2019

Figure 4: Rosacea Phase 1 Clinical Trial Highlights, 2019

Figure 5: Rosacea Preclinical Research Highlights, 2019

Figure 6: Rosacea Discovery Stage Highlights, 2019

For more information about this report visit https://www.researchandmarkets.com/r/aztvvn

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Immune
Disorders Drugs, Clinical
Trials, Dermatological
Drugs